David M. Pariser, MD, FACP, FAAD

home / authors / david-m-pariser-md-facp-faad

Articles

Improving Hyperhidrosis Treatment: The Role of IHhS

Marie Bosslett, Assistant Editor;David M. Pariser, MD, FACP, FAAD

November 11th 2024

David M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.

Latest Updated Articles

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Published: June 6th 2023 | Updated: May 4th 2025

POLL: What Percentage of the Population Has Hidradenitis Suppurativa?

Published: April 29th 2025 | Updated: May 4th 2025

FDA Approves First Gene Therapy for RDEB

$FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria$

Published: April 18th 2025 | Updated: May 4th 2025

FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria

Published: April 22nd 2025 | Updated: May 4th 2025

Using Real-World AD Cases to Pick the Right Therapy for Each Patient

Published: April 1st 2025 | Updated: May 4th 2025

Optimizing Vitiligo Care: Key Expert Takeaways